The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initial results from a phase II study of dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (DA-EPOCH) ± rituximab (R) + tafasitamab (tafa) for adults with newly-diagnosed (ND) Philadelphia chromosome negative (Ph-) B lymphoblastic leukemia (B-ALL).
 
Noam Kopmar
No Relationships to Disclose
 
Jonathan Fromm
No Relationships to Disclose
 
Noah Pinke
No Relationships to Disclose
 
Christen Martino
No Relationships to Disclose
 
Ashtyn Sherrow
No Relationships to Disclose
 
Cristina Ghiuzeli
Employment - Fred Hutchinson Cancer Center; University of Washington
Stock and Other Ownership Interests - Axsome Therapeutics; Bristol Myers Squibb Foundation; crispr therapeutics; Intellia Therapeutics; Ionis Pharmaceuticals; Johnson & Johnson/Janssen; Pfizer; Repare Therapeutics; Sanofi; Syndax; TG Therapeutics; Uniqure; Vertex
 
Raya Mawad
No Relationships to Disclose
 
Ted Gooley
No Relationships to Disclose
 
Jason Cooper
No Relationships to Disclose
 
Erik Kimble
No Relationships to Disclose
 
Bart Scott
Honoraria - Alexion Pharmaceuticals; Alexion Pharmaceuticals; Bristol-Myers Squibb; Incyte; Novartis; Taiho Oncology
Consulting or Advisory Role - Acceleron Pharma; Astex Pharmaceuticals; Celgene; Novartis
Speakers' Bureau - Alexion Pharmaceuticals; Celgene; Jazz Pharmaceuticals; Novartis
Research Funding - Celgene (Inst)
 
Paul Hendrie
No Relationships to Disclose
 
Johnnie Orozco
No Relationships to Disclose
 
Joshua Veatch
Stock and Other Ownership Interests - Lyell Immunopharma; Novo Nordisk
Research Funding - Gilead Sciences
Patents, Royalties, Other Intellectual Property - There are 3 patents on which I am an inventor that have been licensed
 
Mary-Elizabeth Percival
Consulting or Advisory Role - Genentech
Research Funding - Abbvie (Inst); Ascentage Pharma (Inst); Astex Pharmaceuticals (Inst); Biosight (Inst); Cardiff Biotechnology (Inst); Celgene/Bristol-Myers Squibb (Inst); Glycomimetics (Inst); Immunogen (Inst); Oscotec (Inst); Pfizer (Inst); Telios (Inst)
 
Ryan Cassaday
Employment - Seagen (I)
Stock and Other Ownership Interests - Seagen (I)
Honoraria - Kite, a Gilead company; Pfizer
Consulting or Advisory Role - Amgen; Autolus; Jazz Pharmaceuticals; Kite/Gilead; Pfizer
Research Funding - Amgen (Inst); Incyte (Inst); Kite, a Gilead company (Inst); Pfizer; SERVIER (Inst); Vanda Pharmaceuticals
Travel, Accommodations, Expenses - Kite, a Gilead company
Other Relationship - Autolus; Pepromene